Characterization of ceftazidime resistance mechanisms in clinical isolates of burkholderia pseudomallei from Australia

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Sarovich, Derek S ^a   Price, Erin P ^a   von Schulze, Alex T ^a   Cook, James M ^a   Mayo, Mark ^b   Watson, Lindsey M ^a   Richardson, Leisha ^b   Seymour, Meagan L ^a   Tuanyok, Apichai ^a   Engelthaler, David M ^c   Pearson, Talima ^a   Peacock, Sharon J ^d,e   Currie, Bart J ^b   Keim, Paul ^a   Wagner, David M ^a  

^a NORTHERN ARIZONA UNIVERSITY   (United States)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

^c TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^d MAHIDOL UNIVERSITY   (Thailand)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; BETA LACTAM; CEFTAZIDIME; ANTIINFECTIVE AGENT;

AMINO ACID SUBSTITUTION; ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIAL GENE; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BURKHOLDERIA PSEUDOMALLEI; CASE REPORT; DRUG HYDROLYSIS; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PENA GENE; PHENOTYPE; PROMOTER REGION; SINGLE NUCLEOTIDE POLYMORPHISM; UPREGULATION; DNA SEQUENCE; DRUG EFFECT; GENE INACTIVATION; GENETIC COMPLEMENTATION; GENETICS; ISOLATION AND PURIFICATION; MELIOIDOSIS; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; MUTATION;

ANTI-BACTERIAL AGENTS; AUSTRALIA; BURKHOLDERIA PSEUDOMALLEI; CEFTAZIDIME; DRUG RESISTANCE, BACTERIAL; GENE KNOCKOUT TECHNIQUES; GENES, BACTERIAL; GENETIC COMPLEMENTATION TEST; HUMANS; MELIOIDOSIS; MICROBIAL SENSITIVITY TESTS; MUTATION; SEQUENCE ANALYSIS, DNA;

EID: 84857387121     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030789     Document Type: Article

References (34)

1. Tuanyok A, Leadem BR, Auerbach RK, Beckstrom-Sternberg SM, Beckstrom-Sternberg JS, et al. (2008) Genomic islands from five strains of Burkholderia pseudomallei. BMC Genomics 9: 566.
2. Holden MT, Titball RW, Peacock SJ, Cerdeno-Tarraga AM, Atkins T, et al. (2004) Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei. Proc Natl Acad Sci U S A 101: 14240-14245.
3. Dance DA, Wuthiekanun V, Chaowagul W, White NJ, (1989) The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment. J Antimicrob Chemother 24: 295-309.
4. Jenney AW, Lum G, Fisher DA, Currie BJ, (2001) Antibiotic susceptibility of Burkholderia pseudomallei from tropical northern Australia and implications for therapy of melioidosis. Int J Antimicrob Agents 17: 109-113.
5. Moore RA, DeShazer D, Reckseidler S, Weissman A, Woods DE, (1999) Efflux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob Agents Chemother 43: 465-470.
6. Schweizer HP, (2003) Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions. Genet Mol Res 2: 48-62.
7. Godfrey AJ, Wong S, Dance DA, Chaowagul W, Bryan LE, (1991) Pseudomonas pseudomallei resistance to beta-lactam antibiotics due to alterations in the chromosomally encoded beta-lactamase. Antimicrob Agents Chemother 35: 1635-1640.
8. Livermore DM, Chau PY, Wong AI, Leung YK, (1987) beta-Lactamase of Pseudomonas pseudomallei and its contribution to antibiotic resistance. J Antimicrob Chemother 20: 313-321.
9. Burtnick MN, Woods DE, (1999) Isolation of polymyxin B-susceptible mutants of Burkholderia pseudomallei and molecular characterization of genetic loci involved in polymyxin B resistance. Antimicrob Agents Chemother 43: 2648-2656.
10. Viktorov DV, Zakharova IB, Podshivalova MV, Kalinkina EV, Merinova OA, et al. (2008) High-level resistance to fluoroquinolones and cephalosporins in Burkholderia pseudomallei and closely related species. Trans R Soc Trop Med Hyg 102 (Suppl 1): S103-110.
11. Cheng AC, Currie BJ, (2005) Melioidosis: epidemiology, pathophysiology, and management. Clin Microbiol Rev 18: 383-416.
12. Cheng AC, (2010) Melioidosis: advances in diagnosis and treatment. Curr Opin Infect Dis 23: 554-559.
13. Tribuddharat C, Moore RA, Baker P, Woods DE, (2003) Burkholderia pseudomallei class a beta-lactamase mutations that confer selective resistance against ceftazidime or clavulanic acid inhibition. Antimicrob Agents Chemother 47: 2082-2087.
14. Sam IC, See KH, Puthucheary SD, (2009) Variations in ceftazidime and amoxicillin-clavulanate susceptibilities within a clonal infection of Burkholderia pseudomallei. J Clin Microbiol 47: 1556-1558.
15. Rholl DA, Papp-Wallace KM, Tomaras AP, Vasil ML, Bonomo RA, et al. (2011) Molecular Investigations of PenA-mediated beta-lactam Resistance in Burkholderia pseudomallei. Front Microbiol 2: 139.
16. Toohey M, Lew AE, Desmarchelier PM, (1994) Laboratory investigations of Australian isolates of ceftazidime resistant Pseudomonas pseudomallei pp. 1-3.
17. Phillpott R, (1991) Multiple antibiotic resistance Pseudomonas pseudomallei case in South Australia. Communicable Disease Intelligence 15: 270-272.
18. Hamad MA, Zajdowicz SL, Holmes RK, Voskuil MI, (2009) An allelic exchange system for compliant genetic manipulation of the select agents Burkholderia pseudomallei and Burkholderia mallei. Gene 430: 123-131.
19. Bachmann HS, Siffert W, Frey UH, (2003) Successful amplification of extremely GC-rich promoter regions using a novel 'slowdown PCR' technique. Pharmacogenetics 13: 759-766.
20. de Lamballerie X, Zandotti C, Vignoli C, Bollet C, de Micco P, (1992) A one-step microbial DNA extraction method using "Chelex 100" suitable for gene amplification. Res Microbiol 143: 785-790.
21. Germer S, Higuchi R, (1999) Single-tube genotyping without oligonucleotide probes. Genome Res 9: 72-78.
22. Hezard N, Cornillet P, Droulle C, Gillot L, Potron G, et al. (1997) Factor V Leiden: detection in whole blood by ASA PCR using an additional mismatch in antepenultimate position. Thromb Res 88: 59-66.
23. Nadkarni MA, Martin FE, Jacques NA, Hunter N, (2002) Determination of bacterial load by real-time PCR using a broad-range (universal) probe and primers set. Microbiology 148: 257-266.
24. U'Ren JM, Schupp JM, Pearson T, Hornstra H, Friedman CL, et al. (2007) Tandem repeat regions within the Burkholderia pseudomallei genome and their application for high resolution genotyping. BMC Microbiol 7: 23.
25. Godoy D, Randle G, Simpson AJ, Aanensen DM, Pitt TL, et al. (2003) Multilocus sequence typing and evolutionary relationships among the causative agents of melioidosis and glanders, Burkholderia pseudomallei and Burkholderia mallei. J Clin Microbiol 41: 2068-2079.
26. Ambler RP, Coulson AF, Frere JM, Ghuysen JM, Joris B, et al. (1991) A standard numbering scheme for the class A beta-lactamases. Biochem J 276 (Pt 1): 269-270.
27. Price EP, Hornstra HM, Limmathurotsakul D, Max TL, Sarovich DS, et al. (2010) Within-host evolution of Burkholderia pseudomallei in four cases of acute melioidosis. PLoS Pathog 6: e1000725.
28. Currie BJ, Fisher DA, Anstey NM, Jacups SP, (2000) Melioidosis: acute and chronic disease, relapse and re-activation. Trans R Soc Trop Med Hyg 94: 301-304.
29. Desmarchelier PM, Dance DA, Chaowagul W, Suputtamongkol Y, White NJ, et al. (1993) Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis. J Clin Microbiol 31: 1592-1596.
30. Maharjan B, Chantratita N, Vesaratchavest M, Cheng A, Wuthiekanun V, et al. (2005) Recurrent melioidosis in patients in northeast Thailand is frequently due to reinfection rather than relapse. J Clin Microbiol 43: 6032-6034.
31. Limmathurotsakul D, Chaowagul W, Day NP, Peacock SJ, (2009) Patterns of organ involvement in recurrent melioidosis. Am J Trop Med Hyg 81: 335-337.
32. O'Callaghan CH, Acred P, Harper PB, Ryan DM, Kirby SM, et al. (1980) GR 20263, a new broad-spectrum cephalosporin with anti-pseudomonal activity. Antimicrob Agents Chemother 17: 876-883.
33. Gustafsson C, Govindarajan S, Minshull J, (2004) Codon bias and heterologous protein expression. Trends Biotechnol 22: 346-353.
34. Gabor EM, Alkema WB, Janssen DB, (2004) Quantifying the accessibility of the metagenome by random expression cloning techniques. Environ Microbiol 6: 879-886.